Space Force & Biotech: Your Startup's Next Gold Rush!

In this concise briefing, Stacy Chin outlines two emerging dual‑use arenas where U.S. defense spending is creating fresh opportunities for startups. First, the 2026 U.S. Space Force R&D budget is projected to exceed $29 billion, with a focus on satellite networks, orbital communications, autonomous navigation, and related technologies. Chin highlights that startups building small‑satellite launch‑detection systems, in‑orbit servicing capabilities, or AI‑driven space‑situational‑awareness tools can compete for both defense contracts and commercial customers. Second, biotech and biomanufacturing are being elevated to a defense priority: Congress is urging the Department of Defense to accelerate microbial production of fuels, advanced materials, and specialty chemicals, and a new DOD Biotechnology Management Office will coordinate cross‑branch R&D. This opens funding pathways for companies in synthetic biology, biomaterials, health‑security, and biomanufacturing. Throughout, Chin frames these sectors as a “dual‑use gold rush,” urging founders with relevant technologies to engage with both military and commercial markets.










